| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 103 |
| Sex | Female |
| Age Range | 45-64 |
| Body Types | Overweight, Average |
EGCG as PolyPhenon-E was given in either 400mg or 800mg daily for 2 months, no hormonal effects in post-menopausal women and significant reductions in LDL cholesterol were seen.
Reductions in blood glucose and insulin were nonsignificant when compared to baseline, but placebo increased. The difference between placebo and EGCG groups was statistically significant.
No significant differences between 400mg and 800mg.
